Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to ...

Sexual health doesn’t always get the spotlight it deserves. But modern HIV protection platform Mistr PrEP is helping change ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

Gilead Sciences (NASDAQ:GILD) on Wednesday announced a collaboration with the Swiss non-profit The Global Fund to accelerate ...

Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...

Global Fund aims for the first shipment to reach at least one African country by year-end. Read more at straitstimes.com.

Gilead Sciences, in partnership with the Global Fund, plans to supply a long-acting HIV prevention drug to low-income ...

A secondary analysis of a large trial shows that exposure to the HIV drug abacavir is linked to an elevated risk for major ...

The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...

People living with HIV face unique oral health challenges that require special attention and care. The virus's impact on the ...

State's Health Outreach and Prevention program will end June 30 after federal funding cuts to HIV outreach and prevention ...

COVID paused prevention efforts, which helped fuel the rise in new infections. Now federal funding cuts threaten to disrupt those efforts again.